APA Citatie

Figueiredo, A., Atkins, H., Mallick, R., Kekre, N., Kew, A., & McCurdy, A. (2020). Cyclophosphamide–bortezomib–dexamethasone compared with bortezomib–dexamethasone in transplantation-eligible patients with newly diagnosed multiple myeloma. Curr Oncol.

Chicago Style citaat

Figueiredo, A., H. Atkins, R. Mallick, N. Kekre, A. Kew, en A. McCurdy. "Cyclophosphamide–bortezomib–dexamethasone Compared With Bortezomib–dexamethasone in Transplantation-eligible Patients With Newly Diagnosed Multiple Myeloma." Curr Oncol 2020.

MLA citatie

Figueiredo, A., et al. "Cyclophosphamide–bortezomib–dexamethasone Compared With Bortezomib–dexamethasone in Transplantation-eligible Patients With Newly Diagnosed Multiple Myeloma." Curr Oncol 2020.